Related Experiment Videos
Serum albumin, NLR and PLR in pre-treatment assessment of bronchiectasis exacerbations
Reetu G1, Vinod Kumar Viswanathan1
1Department of Respiratory Medicine, Institute of Thoracic Medicine, Madras Medical College, the Tamilnadu Dr. MGR Medical University, Chennai, Tamilnadu, India.
Abstract:
Bronchiectasis severity scores, through useful in disease progression, are inadequate for monitoring exacerbation treatment. Therefore, it is of interest to investigate the correlation between serum albumin, Platelet Lymphocyte Ratio (PLR) and Neutrophil Lymphocyte Ratio (NLR) with disease severity in exacerbated bronchiectasis patients. Serum albumin and NLR demonstrated significant correlation with disease severity, while PLR did not. Post-treatment, both markers showed improvement, indicating their role in treatment monitoring. Thus, we show NLR and serum albumin as reliable biomarkers for assessing severity and monitoring treatment response in bronchiectasis.
Related Concept Videos
Pneumonia III: Complications and Assessment
Nephrotic Syndrome II : Assessment and Medical Management
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Nephrotic Syndrome III : Nursing Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Serum Studies: Renal Function Tests